THAR: Tharimmune, Inc. Stock

by  •  • Comments Off on THAR: Tharimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.04
Enterprise Value ($M) -1.74
Book Value ($M) 3.02
Book Value / Share 1.56
Price / Book 1.01
NCAV ($M) 3.02
NCAV / Share 1.56
Price / NCAV 1.01

Profitability (mra)
Return on Invested Capital (ROIC) -3.60
Return on Assets (ROA) -0.99
Return on Equity (ROE) -1.19

Liquidity (mrq)
Quick Ratio 2.35
Current Ratio 2.35

Balance Sheet (mrq) ($M)
Current Assets 5.25
Assets 5.25
Liabilities 2.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2024-02-14 13G/A Tang Capital Partners Lp 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 1,096 7,217 15.19
2025-03-06 1,493 16,545 9.02
2025-03-05 2,410 36,022 6.69
2025-03-04 38,503 135,976 28.32

(click for more detail)

Similar Companies
TELO – Telomir Pharmaceuticals, Inc. TENX – Tenax Therapeutics, Inc.
TGTX – TG Therapeutics, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc.


Financial data and stock pages provided by
Fintel.io